newsfilter
← Latest News
GlobeNewswire·

resTORbio Presents New Findings on RTB101 During Late-Breaking Session at IDWeek 2019

BOSTON, Oct. 02, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc., (Nasdaq: TORC), a clinical-stage biopharmaceutical company developing innovative medicines that target the biology of aging to prevent or...